Repaglinide 0.5, 1, 2 Mg (2017-04-21)

Repaglinide Recall Summary Repaglinide tablets in 0.5 mg, 1 mg, and 2 mg strengths are being recalled across Canada due to product safety concerns. This is a Class I recall, indicating a serious issue with the medication. The recall affects all repaglinide products distributed in Canada.

Reason

Product safety

Classification

Class I

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2017-06-22

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/682a72e6-218f-4895-9caf-6787b312ea97